C4891029

The Pfizer New Haven Clinical Research Unit is conducting a study of an oral study drug for certain types of breast cancer. This study will look at the effects of the study drug when combined with an additional medication.

Worldwide, breast cancer is the most common invasive cancer, with more than 2.2 million impacted annually. Metastatic breast cancer (mBC), the most advanced stage of breast cancer, remains an incurable disease. Clinical trials help us better understand treatments and give more options to patients who need them.

Read more about how you can lead to discoveries as a healthy volunteer below.

Card Summary Component

Who may participate

People who take part in clinical trials are key to advancing medical research.

This study is seeking healthy adult volunteers, meaning that the participants will not have the condition being studied and are in overall good health. In addition to the criteria listed, participants must meet the following requirements:  

  • Willing to take a study drug
  • Willing and able to come to our facility in New Haven, CT*
  • Able to comply with all study procedures

*Participants may be eligible to receive a bonus for travel, ask our staff for details

**females must be unable to bear children

There are other requirements for participation in this study. The study staff will explain these to you during the screening process.

 

Do you know someone who may meet these requirements? Refer a friend and you may be eligible to receive a bonus. 

Learn more
Condition

Healthy

Age

18-65 years

Sex

All sexes**

Referral bonus

Up to $150

Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.

What to expect

If this study may be a fit for you, you’ll be invited to a screening visit at our facility in New Haven, CT. If you qualify for the study, there may be a period of up to 28 days before dosing.

If you choose to participate, you will stay at our facility for 9 overnights. The morning after admission, you will take a single oral dose of one medication. On the 5th morning, you will take another oral dose of this medication plus a single oral dose of the study drug.

Throughout the study, staff will closely monitor your health status and collect data, such as how you feel and the levels of the study drug in your blood.

Download informed consent form
Required overnight stays

9

Long-term follow up

1 phone call

How long is this study?

Up to about 36 days

Compensation

Up to $3,325 upon completion of the study

All of the study procedures will be clearly explained to you during screening and can be viewed by downloading the informed consent form.

Interested in participating?

Complete and submit this form, and a Pfizer New Haven Clinical Research Unit (PCRU) representative will contact you. Please note: volunteers completing this form must be able to read and speak English at an 8th grade level.

You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.

For Japanese language assistance only, please call 1-833-711-9984. We apologize, our representatives cannot take calls in languages other than English or Japanese at this time.

The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.

Cancel